Literature DB >> 17245063

Imaging of postoperative sensorineural complications of stapes surgery: a pictorial essay.

Denis Ayache1, Delphine Lejeune, Marc T Williams.   

Abstract

Sensorineural hearing loss and/or vertigo are rare but severe complications of stapes surgery for otosclerosis, ranging from 0.2 to 3%. Management of such complications depends on the underlying cause: intravestibular protrusion of the prosthesis, perilymph fistula, labyrinthitis, and reparative granuloma extending into the vestibule. Surgery is mandatory in cases of intravestibular prosthesis or of persistent perilymph fistula. In cases of suppurative labyrinthitis or reparative granuloma extending into the vestibule, prognosis is usually poor, despite aggressive medical therapy or revision surgery. CT scan or magnetic resonance imaging can frequently help to determine the cause of the inner ear complication of stapedectomy. Demonstrative cases are presented to illustrate the prominent place of imaging in managing sensorineural complications of stapes surgery.

Entities:  

Mesh:

Year:  2007        PMID: 17245063     DOI: 10.1159/000098850

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  4 in total

1.  Diagnostic performance of high resolution computed tomography in otosclerosis.

Authors:  Todd Kanzara; Jagdeep Singh Virk
Journal:  World J Clin Cases       Date:  2017-07-16       Impact factor: 1.337

2.  Imaging Studies in Otosclerosis: An Up-to-date Comprehensive Review.

Authors:  Lucas Resende Lucinda Mangia; Luiz Otávio de Mattos Coelho; Bettina Carvalho; Adriana Kosma Pires de Oliveira; Rogerio Hamerschmidt
Journal:  Int Arch Otorhinolaryngol       Date:  2020-09-24

3.  Imaging in otosclerosis: A pictorial review.

Authors:  Bela Purohit; Robert Hermans; Katya Op de Beeck
Journal:  Insights Imaging       Date:  2014-02-09

4.  Intravestibular Stapes Prosthesis Protrusion Causing Post Stapedectomy Vertigo.

Authors:  J P Toirkens; W P A Kelders
Journal:  J Belg Soc Radiol       Date:  2015-12-30       Impact factor: 1.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.